Literature DB >> 25628372

Ovarian cancer risk after salpingectomy: a nationwide population-based study.

Henrik Falconer1, Li Yin2, Henrik Grönberg2, Daniel Altman2.   

Abstract

BACKGROUND: Recent genetic and morphologic studies have challenged the traditional view on the pathogenesis of ovarian cancer; suggesting that ovarian cancer predominantly arises within the fallopian tubes or the uterus. We hypothesize that surgical removal of the fallopian tubes is associated with a reduced risk for ovarian cancer.
METHODS: In this population-based cohort study, we used data on women with previous surgery on benign indication (sterilization, salpingectomy, hysterectomy, and bilateral salpingo-oophorectomy [BSO], hysterectomy; n = 251465) compared with the unexposed population (n = 5449119) between 1973 and 2009 and analyzed with Cox regression models. The effects of one- and two-sided salpingectomy were considered in a subanalysis. All statistical tests were two-sided.
RESULTS: There was a statistically significantly lower risk for ovarian cancer among women with previous salpingectomy (HR = 0.65, 95% CI = 0.52 to 0.81) when compared with the unexposed population. In addition, statistically significant risk reductions were observed among women with previous hysterectomy (HR = 0.79, 95% CI = 0.70 to 0.88), sterilization (HR = 0.72, 95% CI = 0.64 to 0.81), and hysterectomy with BSO (HR = 0.06, 95% CI = 0.03 to 0.12). Bilateral salpingectomy was associated with a 50% decrease in risk of ovarian cancer compared with the unilateral procedure (HR = 0.35, 95% CI = 0.17 to 0.73, and 0.71, 95% CI = 0.56 to 0.91, respectively).
CONCLUSION: Salpingectomy on benign indication is associated with reduced risk of ovarian cancer. These data support the hypothesis that a substantial fraction of ovarian cancer arises in the fallopian tube. Our results suggest that removal of the fallopian tubes by itself, or concomitantly with other benign surgery, is an effective measure to reduce ovarian cancer risk in the general population.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 25628372     DOI: 10.1093/jnci/dju410

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  81 in total

Review 1.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

2.  Uterosacral vault suspension (USLS) at the time of hysterectomy: laparoscopic versus vaginal approach.

Authors:  Sara Houlihan; Shunaha Kim-Fine; Colin Birch; Selphee Tang; Erin A Brennand
Journal:  Int Urogynecol J       Date:  2018-11-05       Impact factor: 2.894

3.  Opportunistic Salpingectomy as an Ovarian Cancer Primary Prevention Strategy.

Authors:  Geetha Balsarkar
Journal:  J Obstet Gynaecol India       Date:  2017-05-11

4.  Re: The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study.

Authors:  Paul J van Diest; Ronald P Zweemer; Jurgen M J Piek
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

5.  Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.

Authors:  F L Potz; G Tomasch; S Polterauer; R Laky; C Marth; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

6.  Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro.

Authors:  L F Freitas; M R Hamblin; F Anzengruber; J R Perussi; A O Ribeiro; V C A Martins; A M G Plepis
Journal:  J Photochem Photobiol B       Date:  2017-05-30       Impact factor: 6.252

Review 7.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

8.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

9.  Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention.

Authors:  Talayeh S Ghezelayagh; Lauren E Stewart; Barbara M Norquist; Deborah J Bowen; Vivian Yu; Kathy J Agnew; Kathryn P Pennington; Elizabeth M Swisher
Journal:  Fam Cancer       Date:  2020-02-24       Impact factor: 2.375

10.  Role of MAPK7 in cell proliferation and metastasis in ovarian cancer.

Authors:  Jinhua Dai; Tao Wang; Weihua Wang; Songhua Zhang; Yufeng Liao; Jie Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.